Squarepoint’s Nutex Health NUTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.63M Buy
+12,420
New +$2.28M ﹤0.01% 1965
2026
Q1
– Sell
-3,624
Closed -$597K – 4735
2025
Q4
$597K Sell
3,624
-1,932
-35% -$256K ﹤0.01% 3065
2025
Q3
$574K Buy
5,556
+3,668
+194% +$360K ﹤0.01% 3131
2025
Q2
$235K Sell
1,888
-8,046
-81% -$1.04M ﹤0.01% 3870
2025
Q1
$467K Buy
9,934
+948
+11% +$46.3K ﹤0.01% 3374
2024
Q4
$285K Buy
+8,986
New +$256K ﹤0.01% 4190
2024
Q1
– Sell
-188
Closed -$5.08K – 4421
2023
Q4
$5.08K Buy
+188
New +$5.86K ﹤0.01% 3936
2023
Q2
– Sell
-1,009
Closed -$153K – 3866
2023
Q1
$153K Buy
1,009
+847
+523% +$172K ﹤0.01% 2885
2022
Q4
$46.2K Buy
+162
New +$31.1K ﹤0.01% 3064

Other funds holding NUTX

Squarepoint's NUTX Position: Q3 2026 in Review

Squarepoint opened a new position in Nutex Health (NUTX) in Q3 2026: 12,420 shares worth $2.63M. The stake represents ﹤0.01% of the portfolio and ranks #1965 among its holdings. This is a return to the name: Squarepoint previously reported a position in NUTX as recently as Q4 2025.

Squarepoint first reported a position in NUTX in Q4 2022 and has held it in 9 quarters since. 85 funds tracked by Wall St. Rank hold NUTX as of Q3 2026.

  • Squarepoint held 12,420 shares of Nutex Health worth $2.63M as of Q3 2026.
  • Nutex Health was a new Squarepoint position in Q3 2026.
  • Nutex Health made up ﹤0.01% of Squarepoint's portfolio in Q3 2026, its #1965 holding.
  • Squarepoint first reported a position in Nutex Health in Q4 2022 and has held it in 9 quarters since.
  • 85 funds tracked by Wall St. Rank held Nutex Health as of Q3 2026.

Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.